JenniferEng-WongMD
Oncology • Washington, DCAssistant Professor, Medicine, Georgetown University School of Medicine
Dr. Eng-Wong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3800 Reservoir Rd Nw
Lombardi Cancer Center
Washington, DC 20007Phone+1 202-444-4948- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
University of California Davis HealthResidency, Internal Medicine, 1996 - 1999
Stony Brook University Health Sciences Center School of MedicineClass of 1996
Certifications & Licensure
DC State Medical License 2000 - 2013
MD State Medical License 2010 - 2012
Clinical Trials
- Raloxifene in Preventing Breast Cancer in Premenopausal Women Start of enrollment: 1998 Dec 01
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Publications & Presentations
PubMed
- 1 citationsPhase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Meta...Jhaveri, K., Bellet, M., Turner, N., Loi, S., Bardia, A., Boni, V., Sohn, J., Neilan, T., Villanueva-Vázquez, R., Kabos, P., García-Estévez, L., López-Miranda, E., Pér...> ;Clinical Cancer Research. 2024 Feb 16
- Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer.Vikram Malhi, Priya Agarwal, Mary R Gates, Lichuan Liu, Jianshuang Wang, Tom De Bruyn, Scott Lam, Jennifer Eng-Wong, Pablo Perez-Moreno, Ya-Chi Chen, Jiajie Yu> ;Cancer Research Communications. 2023 Dec 15
- 6 citationsGiredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao, Bu-Er Wang, Lisa Tai, Jennifer Giltnane, Yuxin Liang, Anneleen Daemen, Heather M Moore, Junko Aimi, Ching-Wei Chang, Mar...> ;Science Translational Medicine. 2022 Sep 21
- Join now to see all
Authored Content
- Long-Term Efficacy Analysis of the Randomised, Phase II TRYPHAENA Cardiac Safety Study: Evaluating Pertuzumab and Trastuzumab plus Standard Neoadjuvant Anthracycline-Containing and Anthracycline-Free Chemotherapy Regimens in Patients with HER2-Positive Early Breast CancerJanuary 2018
Hospital Affiliations
MedStar Georgetown University HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
